Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.68 |
| ▸ | MAOB | P27338 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | BCHE | P06276 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.68 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.68 |
| ▸ | ACHE | P22303 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.68 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.68 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.68 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.68 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.68 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.68 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.68 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735847 | 1.00 | CYP1B1 (0.68) | CYP1B1MAOBMAPTBCHELMNA | |
| SCHEMBL5873205 | 1.00 | CYP1B1 (0.68) | CYP1B1MAOBMAPTBCHELMNA | |
| SCHEMBL30266685 | 0.92 | RELA (0.72) | CYP1B1MAOBMAPTLMNAHDAC3 | |
| SCHEMBL16939624 | 0.92 | RELA (0.72) | CYP1B1MAOBMAPTLMNAHDAC3 | |
| SCHEMBL2649169 | 0.91 | CYP1B1 (0.65) | CYP1B1MAOBMAPTBCHELMNA | |
| SCHEMBL19397672 | 0.91 | CYP1B1 (0.65) | CYP1B1MAOBMAPTBCHELMNA | |
| SCHEMBL1801640 | 0.90 | CYP1B1 (0.73) | CYP1B1MAOBMAPTHDAC3HDAC4 | |
| SCHEMBL9893358 | 0.90 | CYP1B1 (0.69) | CYP1B1MAOBMAPTBCHELMNA | |
| SCHEMBL1801639 | 0.90 | CYP1B1 (0.73) | CYP1B1MAOBMAPTHDAC3HDAC4 | |
| SCHEMBL9893359 | 0.90 | CYP1B1 (0.69) | CYP1B1MAOBMAPTBCHELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| CN-114702460-A | Method for synthesizing 2H-1, 3-oxazine compound by using microchannel reaction device | 南京工业大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-112094226-B | Nitrogen-containing compound, electronic component, and electronic device | 陕西莱特迈思光电材料有限公司 | 2022-03-11 | — | — | CN | disclosed |
| WO-2022045325-A1 | CARBAZOLE COMPOUND, AND FUNCTIONAL MATERIAL AND LIGHT EMITTING ELEMENT THAT INCLUDE SAME | 平賀 靖英 | 2022-03-03 | — | — | WO | disclosed |
| WO-2022042267-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE | 陕西莱特迈思光电材料有限公司 | 2022-03-03 | — | — | WO | disclosed |
| CN-112094226-A | Nitrogen-containing compound, electronic component, and electronic device | 陕西莱特迈思光电材料有限公司 | 2020-12-18 | — | — | CN | disclosed |
| US-7067702-B2 | Process for preparing vinyl substituted beta-diketones | THE JOHNS HOPKINS UNIVERSITY (US) | 2006-06-27 | — | — | US | disclosed |
| US-20060069288-A1 | Process for preparing vinyl substituted beta-diketones | THE JOHNS HOPKINS UNIVERSITY | 2006-03-30 | — | — | US | disclosed |
| US-3989708-A | HYPOTENSIVE, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069288-A1 | Process for preparing vinyl substituted beta-diketones | VRK1, VRK2, DEK | CYP1B1 996/4885MAOB 1616/4885MAPT 4054/4885 |
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | CNOT1, NXF1, NR2E1 | CYP1B1 819/4885MAOB 1798/4885MAPT 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.